These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 15514089)
21. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. Mao Y; Ling PR; Fitzgibbons TP; McCowen KC; Frick GP; Bistrian BR; Smith RJ Endocrinology; 1999 Dec; 140(12):5505-15. PubMed ID: 10579313 [TBL] [Abstract][Full Text] [Related]
22. Cross-talk between the insulin and angiotensin signaling systems. Velloso LA; Folli F; Sun XJ; White MF; Saad MJ; Kahn CR Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12490-5. PubMed ID: 8901609 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Kawaguchi T; Yoshida T; Harada M; Hisamoto T; Nagao Y; Ide T; Taniguchi E; Kumemura H; Hanada S; Maeyama M; Baba S; Koga H; Kumashiro R; Ueno T; Ogata H; Yoshimura A; Sata M Am J Pathol; 2004 Nov; 165(5):1499-508. PubMed ID: 15509521 [TBL] [Abstract][Full Text] [Related]
24. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway. Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921 [TBL] [Abstract][Full Text] [Related]
25. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583 [TBL] [Abstract][Full Text] [Related]
26. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. Senn JJ; Klover PJ; Nowak IA; Zimmers TA; Koniaris LG; Furlanetto RW; Mooney RA J Biol Chem; 2003 Apr; 278(16):13740-6. PubMed ID: 12560330 [TBL] [Abstract][Full Text] [Related]
27. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor. Tomic S; Chughtai N; Ali S Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404 [TBL] [Abstract][Full Text] [Related]
28. Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells. Cui TX; Nakagami H; Nahmias C; Shiuchi T; Takeda-Matsubara Y; Li JM; Wu L; Iwai M; Horiuchi M Mol Endocrinol; 2002 Sep; 16(9):2113-23. PubMed ID: 12198247 [TBL] [Abstract][Full Text] [Related]
29. Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes. Tajmir P; Kwan JJ; Kessas M; Mozammel S; Sweeney G J Cell Physiol; 2003 Oct; 197(1):122-30. PubMed ID: 12942548 [TBL] [Abstract][Full Text] [Related]
30. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells. Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961 [TBL] [Abstract][Full Text] [Related]
31. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630 [TBL] [Abstract][Full Text] [Related]
32. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells. Sweeney G; Keen J; Somwar R; Konrad D; Garg R; Klip A Endocrinology; 2001 Nov; 142(11):4806-12. PubMed ID: 11606447 [TBL] [Abstract][Full Text] [Related]
33. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. McWhinney CD; Dostal D; Baker K J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424 [TBL] [Abstract][Full Text] [Related]
34. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2. Chibalin AV; Yu M; Ryder JW; Song XM; Galuska D; Krook A; Wallberg-Henriksson H; Zierath JR Proc Natl Acad Sci U S A; 2000 Jan; 97(1):38-43. PubMed ID: 10618367 [TBL] [Abstract][Full Text] [Related]
35. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. van de Geijn GJ; Gits J; Touw IP J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455 [TBL] [Abstract][Full Text] [Related]
36. Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. González-Yanes C; Sánchez-Margalet V Diabetes; 2000 Aug; 49(8):1288-94. PubMed ID: 10923627 [TBL] [Abstract][Full Text] [Related]
37. Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway. Amaral ME; Ueno M; Carvalheira JB; Carneiro EM; Velloso LA; Saad MJ; Boschero AC Horm Metab Res; 2003 May; 35(5):282-9. PubMed ID: 12915997 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. Bousquet C; Susini C; Melmed S J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526 [TBL] [Abstract][Full Text] [Related]
39. Enhanced insulin action on glucose transport and insulin signaling in 7-day unweighted rat soleus muscle. O'Keefe MP; Perez FR; Sloniger JA; Tischler ME; Henriksen EJ J Appl Physiol (1985); 2004 Jul; 97(1):63-71. PubMed ID: 15004002 [TBL] [Abstract][Full Text] [Related]
40. Expression of a mutant IRS inhibits metabolic and mitogenic signalling of insulin in human adipocytes. Stenkula KG; Said L; Karlsson M; Thorn H; Kjølhede P; Gustavsson J; Söderström M; Strålfors P; Nystrom FH Mol Cell Endocrinol; 2004 Jun; 221(1-2):1-8. PubMed ID: 15223127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]